Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
International Journal of Molecular Sciences
|
February 15, 2022
Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma
Virginia Albiñana, Lucía Recio-Poveda, Pilar González-Peramato, et al.
Journal of Clinical Medicine
|
August 12, 2022
Propranolol: A "Pick and Roll" Team Player in Benign Tumors and Cancer Therapies
Virginia Albiñana, Eunate Gallardo-Vara, Juan Casado-Vela, et al.
Stem Cells (Dayton, Ohio)
|
December 20, 2008
Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds
Marta Compte, Angel M Cuesta, David Sánchez-Martín, et al.
Immunology
|
March 25, 2006
Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I
Angel M Cuesta, Eduardo Suárez, Martin Larsen, et al.
Journal of Clinical Medicine
|
June 11, 2020
Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding
Virginia Albiñana, Angel M Cuesta, Isabel de Rojas-P, et al.
Cells
|
September 28, 2021
The Endothelial Landscape and Its Role in Von Hippel-Lindau Disease
Isabel de Rojas-P, Virginia Albiñana, Lyudmyla Taranets, et al.
Plos One
|
April 30, 2009
In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences
Angel M Cuesta, David Sánchez-Martín, Laura Sanz, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
July 31, 2019
Topically Applied Etamsylate: A New Orphan Drug for HHT-Derived Epistaxis (Antiangiogenesis through FGF Pathway Inhibition)
Virginia Albiñana, Guillermo Giménez-Gallego, Angela García-Mato, et al.
International Journal of Cancer
|
February 16, 2006
Enhanced antiangiogenic therapy with antibody-collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events
Víctor J Sánchez-Arévalo Lobo, Angel M Cuesta, Laura Sanz, et al.
Cancer Research
|
January 18, 2018
PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα
Higinio Dopeso, Hui-Ke Jiao, Angel M Cuesta, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
International Journal of Molecular Sciences
|
February 15, 2022
Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma
Virginia Albiñana, Lucía Recio-Poveda, Pilar González-Peramato, et al.
Journal of Clinical Medicine
|
August 12, 2022
Propranolol: A "Pick and Roll" Team Player in Benign Tumors and Cancer Therapies
Virginia Albiñana, Eunate Gallardo-Vara, Juan Casado-Vela, et al.
Stem Cells (Dayton, Ohio)
|
December 20, 2008
Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds
Marta Compte, Angel M Cuesta, David Sánchez-Martín, et al.
Immunology
|
March 25, 2006
Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I
Angel M Cuesta, Eduardo Suárez, Martin Larsen, et al.
Journal of Clinical Medicine
|
June 11, 2020
Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding
Virginia Albiñana, Angel M Cuesta, Isabel de Rojas-P, et al.
Cells
|
September 28, 2021
The Endothelial Landscape and Its Role in Von Hippel-Lindau Disease
Isabel de Rojas-P, Virginia Albiñana, Lyudmyla Taranets, et al.
Plos One
|
April 30, 2009
In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences
Angel M Cuesta, David Sánchez-Martín, Laura Sanz, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
July 31, 2019
Topically Applied Etamsylate: A New Orphan Drug for HHT-Derived Epistaxis (Antiangiogenesis through FGF Pathway Inhibition)
Virginia Albiñana, Guillermo Giménez-Gallego, Angela García-Mato, et al.
International Journal of Cancer
|
February 16, 2006
Enhanced antiangiogenic therapy with antibody-collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events
Víctor J Sánchez-Arévalo Lobo, Angel M Cuesta, Laura Sanz, et al.
Cancer Research
|
January 18, 2018
PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα
Higinio Dopeso, Hui-Ke Jiao, Angel M Cuesta, et al.
Page
of 4